Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma.

about

Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma.

Item

http://www.wikidata.org/entity/Q41008543

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Complete response after rechal ...... rade undifferentiated sarcoma.

@en

type

Item

label

Complete response after rechal ...... rade undifferentiated sarcoma.

@en

prefLabel

Complete response after rechal ...... rade undifferentiated sarcoma.

@en

P1476

Complete response after rechal ...... rade undifferentiated sarcoma.

@en

P2093

Elisabetta Parisi

http://www.w3.org/2001/XMLSchema#string

Giacomo G Baldi

http://www.w3.org/2001/XMLSchema#string

Lorenzo Fantini

http://www.w3.org/2001/XMLSchema#string

Manjola Dona

http://www.w3.org/2001/XMLSchema#string

Mauro Panella

http://www.w3.org/2001/XMLSchema#string

Rossana Fargnoli

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.

A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas.

Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study.

Efficacy of trabectedin in metastatic solitary fibrous tumor.

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

Trabectedin for desmoplastic small round cell tumours: a possible treatment option?

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.

P304

908-913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/CAD.0000000000000398

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rossella Bertulli

Marta Sbaraglia

Samantha Di Donato

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27348763

http://www.w3.org/2001/XMLSchema#string

P932

5010279

http://www.w3.org/2001/XMLSchema#string